Has Mutessa Murray received payments from drug or device companies?

Yes. Drug and device makers reported $3,309 in general payments to Mutessa Murray across 69 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mutessa Murray did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mutessa Murray come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mutessa Murray

Family · Miami, FLNPI 1265521124

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations.

$3,309in general payments, 2019–2025

Across 69 payments — averaging $47.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$552
Boston Scientific$533
Cleerly, Inc.$249
Pfizer$246
AstraZeneca$239
Abbott$223
plus $1K from 15 others

What the payments were for

Food & beverage$3,20997%
Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	4	$552
Boston Scientific	5	$533
Cleerly, Inc.	2	$249
Pfizer	12	$246
AstraZeneca(2 entities)	9	$239
Abbott	4	$223
E.r. Squibb & Sons, L.L.C.	11	$216
Impulse Dynamics (USA) Inc.	2	$195
Edwards Lifesciences	1	$186
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	5	$143
Novo Nordisk	1	$125
ETS Wound Care LLC	1	$93
Cvrx, Inc.	1	$77
Novartis	2	$48
Amgen	2	$37
Paratek Pharmaceuticals, Inc.	2	$33
Johnson & Johnson	1	$27
Biosense Webster, Inc.	1	$27
Bayer	1	$22
Esperion Therapeutics, Inc.	1	$20
Lexicon Pharmaceuticals, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,309 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	12	$49

Paid to pharmacies, not to this prescriber.

Other family in Miami

Patrick SzarazMiami$327K
Yamila MelendezMiami$212K
Suzan RosenMiami$129K
Felipe NovoaMiami$110K
Pamela DudkiewiczMiami$89K
Stacy FeemsterMiami$51K
Estrella Moreno RodriguezMiami$30K
Lewis HarringtonTampa$954K
Danielle PharesFt Lauderdale$713K
Donna OrtizOrlando$417K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →